Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Multi-Target Antitumor Effects of Natural Products and Approved Drug Repurposing in Non-Small Cell Lung Cancer: Advances in Mechanisms, Combination Regimens, Delivery System Optimization, and Clinical Challenges
International Journal of Molecular Sciences
September 2026
Xie Y.
Open Access
The combination of rosuvastatin and meloxicam enhances the radiotherapy efficacy of MCF7, T-47D, and MDA-MB-231 breast cancer cell lines
Research in Pharmaceutical Sciences
1 January 2026
Naeimi A.
Open Access
Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential
Frontiers in Immunology
2026
Su J.
Open Access
Repositioning of drugs in non-small cell lung cancer: Old weapons for a new war
Drug Repurposing Novel Therapeutic Avenues and Innovations in Healthcare
10 March 2025
Pal R.
The effect and mechanism of atorvastatin regulating PI3K-Akt–mTOR pathway on radiosensitivity of hepatocellular carcinoma cells
Toxicology Research
1 February 2025
Deng Z.
All Open Access, Green
The Efficacy of Oral Atorvastatin for Skin Toxicity in Breast Cancer Patients Undergoing Radiotherapy: A Randomized, Double-blind, Placebo-controlled Trial
Current Pharmaceutical Design
2025
Danesh M.
Design, synthesis and biological evaluation of (E)-kojyl-styryl-sulfones: Novel recilisib hybrids as promising radioprotectors
Archiv Der Pharmazie
January 2025
Ahmadi R.
Microneedles integrated with atorvastatin-loaded pumpkisomes for breast cancer therapy: A localized delivery approach
Journal of Controlled Release
December 2024
Heikal L.A.
XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures
Computers in Biology and Medicine
January 2024
Wang Y.
Gliclazide protects ionizing radiation-induced intestinal injury in mice by inhibiting oxidative stress and caspase-3
Biotechnologia
2024
Arzani S.
Open Access
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
Current Oncology
January 2023
Doumat G.
Open Access
Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
Medicina Lithuania
September 2022
Gales L.
Open Access
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employees
Thoracic Cancer
August 2022
Chen Z.H.
Open Access
Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
Cancers
July 2022
Pereira M.
Open Access
Potential of vasoprotectives to inhibit non-enzymatic protein glycation, and reactive carbonyl and oxygen species uptake
International Journal of Molecular Sciences
September 2021
Bednarska K.
Open Access